Picture of InspireMD logo

NSPR InspireMD News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Brief: InspireMD Reports Publication of 12-Month Results of CGuard EPS SIBERIA Trial

Nov 3 (Reuters) - InspireMD Inc  NSPR.O :
    * INSPIREMD ANNOUNCES PUBLICATION OF 12-MONTH RESULTS OF
CGUARD™
EPS SIBERIA TRIAL IN JOURNALS OF THE AMERICAN COLLEGE OF
CARDIOLOGY: CARDIOVASCULAR INTERVENTIONS

Source text for Eikon:  ID:nGNX88b4R9 
Further company coverage:  NSPR.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on InspireMD

See all news